![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Krebs Biochemicals & Industries Limited Kothapalli In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Simvastatin, with 0.2% butylated hydroxy anisole, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-210 - Rev 02
This Chemical Type CEP, issued on August 11, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1563 associated with this CEP further emphasizes